Evidence map›Paper›PMID 17377770›Full record

Trial reportIntensive care medicine2007

Intravenous fish oil blunts the physiological response to endotoxin in healthy subjects.

Thomas-Thi Pluess, Daniel Hayoz, Mette M Berger, Luc Tappy, Jean-Pierre Revelly, Burkhard Michaeli, Yvon A Carpentier, René L Chioléro

Erratum issued 2 registry-linked trialsOpen access · bronzeAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Intensive care medicine, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03792087 phase3completednot on this mapstarted 2017, after this paper: background citation

Efficacy & Safety of SmofKabiven Peripheral vs Compounded Emulsion: A Randomized, Active-Controlled, Open-Labelled, Multi-Centre Study in Adult Surgical Patients Requiring Parenteral Nutrition

TypeinterventionalSponsorFresenius KabiRan2017 to 2018Enrolled272ConditionsParenteral Feeding, SurgeryArmsSmofKabiven Peripheral, Hospital compounded emulsion
NCT03792100 phase3completednot on this mapstarted 2019, after this paper: background citation

Efficacy & Safety of SmofKabiven Emulsion for Infusion vs Hospital Compounded "All in One" for Parenteral Nutrition (PN): A Randomized, Active-Controlled, Patient-blinded, Multi-Centre Study in Adult Surgical Patients Requiring PN

TypeinterventionalSponsorFresenius KabiRan2019 to 2020Enrolled273ConditionsParenteral Nutrition, SurgeryArmsSmofKabiven emulsion for infusion, Hospital compounded "All in one" emulsion
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 92 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Does an acute inflammatory response temporarily attenuate parasympathetic reactivation?Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2010
    Trial
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Effect of Oral ω3-Polyunsaturated Fatty Acids as a Complement Management to Control Fistula Output and Inflammation in Patients With Digestive Fistula.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2017
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Resolvin D1 improves survival in experimental sepsis through reducing bacterial load and preventing excessive activation of inflammatory response.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2014
    Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Thomas-Thi PluessDepartment of Intensive Care Medicine, CHUV, 1011, Lausanne, Switzerland.
Daniel HayozDivision of Hypertension and Vascular Medicine, CHUV, 1011, Lausanne, Switzerland.
Mette M BergerDepartment of Intensive Care Medicine, CHUV, 1011, Lausanne, Switzerland.
Luc TappyInstitute of Human Physiology, University of Lausanne, 1011, Lausanne, Switzerland.
Jean-Pierre RevellyDepartment of Intensive Care Medicine, CHUV, 1011, Lausanne, Switzerland.
Burkhard MichaeliDepartment of Intensive Care Medicine, CHUV, 1011, Lausanne, Switzerland.
Yvon A CarpentierLaboratory of Experimental Surgery, Université Libre de Bruxelles, Brussels, Belgium.
René L ChioléroDepartment of Intensive Care Medicine, CHUV, 1011, Lausanne, Switzerland. rene.chiolero@chuv.ch.
University Hospital of Lausanne · CHUniversité Libre de Bruxelles · BEUniversity of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the effects of intravenous fish oil fat emulsion on the metabolic alterations induced by lipopolysaccharide (LPS) challenge in healthy volunteers.

designTwo groups of eight healthy subjects were randomized to receive either two pharmacological doses of intravenous FO fat emulsion or no treatment. The FO group received twice 0.5 g/kg 10% emulsion (Omegaven) 48 and 24h before investigation. LPS (2 ng/kg) was injected as a bolus on the investigation day. Systemic parameters, indirect calorimetry, heart rate variability, and platelet membrane phospholipid composition were measured.

resultsBasal EPA and DHA content in platelet phospholipids was low (0.28% and 2.54%, respectively) and increased significantly after FO to 1.68% and 3.32%. LPS induced reproducible effects in all subjects. Fever was higher in the control [corrected] group than in FO group [corrected] the difference was significant from t (120) until t (360). FO blunted the neuroendocrine response: the rise in plasma norepinephrine was sevenfold lower at t (120) while the ACTH peak was fourfold lower. Tumor necrosis factor alpha was significantly lower between t (360) and t (180) in the FO group.

conclusionsTwo doses of intravenous FO fat emulsion modified the phospholipid composition of platelets in healthy subjects. FO blunted fever and increased the neuroendocrine and the inflammatory responses to LPS.

Indexed as

Fat Emulsions, IntravenousLipopolysaccharidesAdultBaroreflexEndotoxinsFish OilsHeart RateHumansInflammationMaleEndotoxinsFat Emulsions, IntravenousFish OilsLipopolysaccharides

Identifiers

PMID17377770
OpenAlexW2089005015

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.